Application of Radiopharmaceuticals in Targeted Tumor Therapies
- Author:
Tao-Tao ZHANG
1
;
Hong ZHANG
1
;
Cui-Xia DI
1
;
Tao-Tao ZHANG
2
;
Hong ZHANG
2
;
Cui-Xia DI
2
;
Tao-Tao ZHANG
3
;
Hong ZHANG
3
;
Cui-Xia DI
3
;
Tao-Tao ZHANG
4
;
Hong ZHANG
4
;
Cui-Xia DI
4
;
Tao-Tao ZHANG
5
;
Hong ZHANG
5
;
Cui-Xia DI
5
;
Tao-Tao ZHANG
6
Author Information
- Publication Type:Journal Article
- Keywords: clinical application; radiopharmaceutical; targeted therapy; tumor
- From: Chinese Journal of Biochemistry and Molecular Biology 2022;38(11):1435-1442
- CountryChina
- Language:Chinese
- Abstract: Radiopharmaceuticals are radionuclide preparations or radiolabelled compounds used for clinical diagnosis or treatment. The targeted radionuclide therapy uses molecular carriers with high affinity for tumor cells to target radionuclides into specific tumor tissues to treat tumors. Compared with traditional radiotherapy and chemotherapy, it is more selective. With the development of nuclear medicine, the popularization of SPECT/CT, PET/CT, the discovery of new targets and the development of new radiopharmaceuticals, the targeted therapy with radiopharmaceuticals is playing an increasingly important role in the clinical treatment of tumors. This review briefly describes the classification, composition and characteristics of radiopharmaceuticals; the application of radioimmunodrugs targeting tumor-associated antigen in non-Hodgkin's lymphoma, colorectal cancer and prostate cancer; the clinical application of receptor-mediated radionuclide drugs in the treatment of neuroendocrine tumors, prostate cancer and breast cancer, and the research progress of radiopharmaceuticals based on gene modification in targeted tumor therapies. Finally, the application prospects and challenges of radiopharmaceuticals in cancer treatment are summarized in order to provide some references for the development and clinical application of radiopharmaceuticals for targeted tumor therapy.
